Britain's GSK vows $30 bn investment in US as Trump visits | Business

LONDON, Sept 17, 2025 (BSS/AFP) - British pharmaceutical group GSK said Wednesday it will invest $30 billion in the United States over the next five years, as drugmakers face pressure from US President Donald Trump to produce more in the country. The investments, announced on the first day of Trump's state visit to Britain, will bolster GSK's research and development as well as production capacities in the United States, the company said. Trump unleashed a barrage of tariffs after his re-election in a bid to force a range of industries to increase domestic production, accusing them of contributing to an "unfair" US trade deficit. "This week's state visit brings together two countries that have led the world in science and...